Moreover, a "NSCLC-pathway" containing TNF, PI3K-Akt and VEGF signaling pathways was assembled and separated into two represent therapeutic modules (immunization module and tumor related module). The gene discussed is PIK3CG; the disease is non-small cell lung carcinoma.